article thumbnail

Connected Medical Devices—the Next Target for Ransomware Attacks

Healthcare IT Today

Food and Drug Administration (FDA) has recognized the problem and issued multiple guidance documents over the years—as recently as this March —to ensure the cybersecurity of medical devices. Although none of the FDA recommendations are legally enforceable, device manufacturers no longer have a choice but to comply.

article thumbnail

Prescriptions Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA’s 2024 Update

Health Populi

The annual report details trends in health services utilization, the use of prescription drugs, patient financing of those costs, the drivers underpinning the medicines spending, and an outlook to 2028. Oncology and obesity will drive significant growth through 2028, IQVIA expects.

FDA 71
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Advances in Early Diagnosis

Healthcare IT Today

Nutromics’s measurement solution will be available commercially in 2028. This diagnostic tool is a big advance, and won FDA approval in 2022. Having completed their clinical study, Cordio Medical is submitting the app for FDA approval. They plan many other applications for the Nutromics patch. This can save lives.

Doctors 122
article thumbnail

A Whole New World for Laboratory Developed Tests – FDA Proposes End to Its Longstanding Policy of Enforcement Discretion

Hall Render

On September 29, 2023, the Food and Drug Administration (“FDA”) announced the issuance of a Notice of Proposed Rulemaking (the “Proposed Rule”) to expand the FDA’s regulatory scope over in vitro diagnostics products (“IVDs”) to specifically address Laboratory Developed Tests (“LDTs”).

FDA 40
article thumbnail

From Discretion to Regulation: What FDA’s Final Rule Means for Laboratory Developed Tests

Hall Render

In April 2024, the Food and Drug Administration (“FDA”) issued a Final Rule amending the definition of in vitro diagnostics products (“IVDs”) found in 21 C.F.R. Stage 3: Effective May 6, 2027 Three years after the Final Rule’s publication, the FDA will enforce all remaining quality system requirements (under 21 C.F.R.

FDA 40
article thumbnail

A Step-by-step guide to Medical Device Quality System Management

Dot Compliance

The two most relevant quality regulations for medical device manufacturers are the FDA 21 CFR Part 820 and the ISO 13485:2016. The QMS supports the manufacturers, leading to ISO confirmation and FDA compliance. The FDA 21 CFR Part 820 is the mandatory standard for medical devices distributed in the US.

FDA 52
article thumbnail

Connecting the Dots – Building Data Bridges for a Better Healthcare Future

HIT Consultant

Simple-to-use and portable consumer EKG devices that are FDA-cleared allow patients to capture this information at home and as symptoms occur, providing another window into the patient’s health that goes beyond the four walls of the traditional healthcare provider.